Literature DB >> 12115548

Prevalence of human papillomavirus in cervical cancer: a multicenter study in China.

Keith W K Lo1, Y F Wong, May K M Chan, James C B Li, J S Poon, Vivian W Wang, S N Zhu, T M Zhang, Z G He, Q L Wu, G D Li, John S L Tam, T Kahn, P Lam, T H Cheung, Tony K H Chung.   

Abstract

A large-scale epidemiologic survey on the prevalence of different types of human papillomavirus (HPV) in cervical cancer in China is indicated because of the implications for the development of diagnostic probes and vaccines against cervical cancer. A total of 809 cervical cancer specimens were collected from 5 regions in China including Shanghai, Guangzhou, Sichuan, Beijing and Hong Kong. HPV DNA was detected in 83.7% of the specimens. HPV-16 was present in 79.6%, HPV-18 in 7.5%, HPV-52 in 2.6% and HPV-58 in 3.8% of all HPV-positive specimens. The prevalences of HPV-16 and HPV-18 in Hong Kong were 61.7 and 14.8%, respectively, representing a lower HPV-16 and a higher HPV-18 proportion compared with the other regions. HPV-16 remained the most common HPV infection in both squamous cell carcinoma (SCC) and adenocarcinoma (AC). The proportion of HPV-18 infection was significantly higher in AC than in SCC. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115548     DOI: 10.1002/ijc.10506

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Detection of HPV types and neutralizing antibodies in women with genital warts in Tianjin City, China.

Authors:  Xue-ling Wu; Chun-tao Zhang; Xiao-ke Zhu; You-chun Wang
Journal:  Virol Sin       Date:  2010-02-12       Impact factor: 4.327

Review 2.  HPV prevalence and genotyping in the cervix of Chinese women.

Authors:  Shao-Ming Wang; Jing Li; You-Lin Qiao
Journal:  Front Med China       Date:  2010-09-09

Review 3.  Current issues facing the introduction of human papillomavirus vaccine in China and future prospects.

Authors:  Li Ping Wong; Liyuan Han; Hui Li; Jinshun Zhao; Qinjian Zhao; Gregory D Zimet
Journal:  Hum Vaccin Immunother       Date:  2019-07-16       Impact factor: 3.452

4.  Age-period-cohort analysis of cervical cancer incidence in Hong Kong from 1972 to 2001 using maximum likelihood and Bayesian methods.

Authors:  Gabriel M Leung; Pauline P S Woo; Sarah M McGhee; Annie N Y Cheung; Susan Fan; Oscar Mang; Thuan Q Thach; Hextan Y S Ngan
Journal:  J Epidemiol Community Health       Date:  2006-08       Impact factor: 3.710

5.  High risk HPV types in southern Iranian patients with cervical cancer.

Authors:  S Farjadian; E Asadi; M Doroudchi; A Samsami Dehaghani; S Z Tabei; V P Kumar; A Ghaderi
Journal:  Pathol Oncol Res       Date:  2003-07-14       Impact factor: 3.201

6.  Increase of integration events and infection loads of human papillomavirus type 52 with lesion severity from low-grade cervical lesion to invasive cancer.

Authors:  Jo L K Cheung; T H Cheung; Julian W T Tang; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

7.  Variants of human papillomavirus type 16 predispose toward persistent infection.

Authors:  Lei Zhang; Hong Liao; Binlie Yang; Christopher P Geffre; Ai Zhang; Aizhi Zhou; Huimin Cao; Jieru Wang; Zhenbo Zhang; Wenxin Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

8.  Prediction and identification of human leukocyte antigen-A2-restricted cytotoxic T lymphocyte epitope peptides from the human papillomavirus 58 E7 protein.

Authors:  He Wang; Lilai Chen; Weihong Ma; Yue Zeng; Lu Qin; Mengjie Chen; Li Li
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

9.  Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.

Authors:  Yue-Mei Hu; Shou-Jie Huang; Kai Chu; Ting Wu; Zhong-Ze Wang; Chang-Lin Yang; Jia-Ping Cai; Han-Min Jiang; Yi-Jun Wang; Meng Guo; Xiao-Hui Liu; Hong-Jiang Huang; Feng-Cai Zhu; Jun Zhang; Ning-Shao Xia
Journal:  Hum Vaccin Immunother       Date:  2013-10-25       Impact factor: 3.452

10.  Evaluation of high-risk human papillomaviruses type distribution in cervical cancer in Sichuan province of China.

Authors:  En-qi Wu; Guo-nan Zhang; Xiang-hui Yu; Yuan Ren; Ying Fan; Yong-ge Wu; Wei Kong; Xiao Zha
Journal:  BMC Cancer       Date:  2008-07-22       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.